A young woman with a long history of migraines and vertigo struggled with ineffective treatments until she started CGRP inhibitors. After monthly injections, her migraines drastically improved from daily attacks to just a few per month, greatly enhancing her quality of life. Her experience highlights the potential of targeted therapies like CGRP antibodies when traditional options fail.
A young woman with a long history of migraines and dizziness shares her personal story. She explains that she has experienced vertical issues and daily migraines since she was 15 years old. Despite seeking help, her condition remained persistent and debilitating, severely affecting her quality of life. Her symptoms included frequent vertigo and an inability to find relief through standard treatments.
Initially, she underwent various treatments, including migraine diets and preventive medications. She tried multiple drugs such as topiramate, propranolol, verapamil, and nortriptyline, but none of these provided relief. Additionally, she received nerve blocks like the sphenopalatine block and even Botox injections. Despite these efforts, her migraines and related symptoms persisted, leaving her frustrated and desperate for an effective solution.
Her journey through treatment was challenging, and she experienced negative reactions to some therapies, like Botox. Her condition continued to worsen until she was introduced to a new medication targeting CGRP (calcitonin gene-related peptide). This medication was administered monthly via injections, representing a novel approach compared to her previous treatments. Remarkably, she saw significant improvement within about a week of starting this therapy.
Following the CGRP treatment, her migraines decreased dramatically—from daily attacks to only about three episodes per month. This reduction allowed her to stop taking commonly used rescue medications like Tylenol and meclizine, which she previously relied on for vertigo and headache relief. Her quality of life improved substantially, thanks to this targeted therapy that addressed the underlying cause of her migraines.
The doctor emphasizes that her vertigo and dizziness were all related to her chronic migraines, not inner ear problems. The case highlights how traditional migraine treatments can sometimes fall short, and how exploring comprehensive and newer options like CGRP inhibitors can make a significant difference. The doctor encourages others with similar conditions to systematically try different treatments, as her story could serve as an inspiration for those still searching for effective relief.